- Home
- INKT vs LITB Comparison
INKT vs LITB Comparison
Compare INKT & LITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- LITB
- Stock Information
- Founded
- INKT 2017
- LITB 2007
- Country
- INKT United States
- LITB Singapore
- Employees
- INKT N/A
- LITB N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- LITB Catalog/Specialty Distribution
- Sector
- INKT Health Care
- LITB Consumer Discretionary
- Exchange
- INKT Nasdaq
- LITB Nasdaq
- Market Cap
- INKT 36.7M
- LITB N/A
- IPO Year
- INKT 2021
- LITB N/A
- Fundamental
- Price
- INKT $8.43
- LITB $1.00
- Analyst Decision
- INKT Strong Buy
- LITB
- Analyst Count
- INKT 2
- LITB 0
- Target Price
- INKT $19.50
- LITB N/A
- AVG Volume (30 Days)
- INKT 11.3K
- LITB 21.3K
- Earning Date
- INKT 03-18-2025
- LITB 03-24-2025
- Dividend Yield
- INKT N/A
- LITB N/A
- EPS Growth
- INKT N/A
- LITB N/A
- EPS
- INKT N/A
- LITB N/A
- Revenue
- INKT N/A
- LITB $333,093,000.00
- Revenue This Year
- INKT N/A
- LITB N/A
- Revenue Next Year
- INKT N/A
- LITB N/A
- P/E Ratio
- INKT N/A
- LITB N/A
- Revenue Growth
- INKT N/A
- LITB N/A
- 52 Week Low
- INKT $4.56
- LITB $0.91
- 52 Week High
- INKT $19.00
- LITB $6.00
- Technical
- Relative Strength Index (RSI)
- INKT 41.71
- LITB 39.53
- Support Level
- INKT $7.54
- LITB $0.92
- Resistance Level
- INKT $8.88
- LITB $1.05
- Average True Range (ATR)
- INKT 0.86
- LITB 0.06
- MACD
- INKT -0.25
- LITB 0.01
- Stochastic Oscillator
- INKT 6.05
- LITB 26.92
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.